#mte #meettheexperts #Pretestdatenbank #Pretest
Neues #Video im #YouTube-Kanal: Dr. Timo Lenzner stellt die GESIS Pretest-Datenbank vor, die Pretestergebnisse zu über 3.000 getesteten Survey-Items enthält. Jetzt reinschauen!
#mte #meettheexperts #Pretestdatenbank #Pretest
Neues #Video im #YouTube-Kanal: Dr. Timo Lenzner stellt die GESIS Pretest-Datenbank vor, die Pretestergebnisse zu über 3.000 getesteten Survey-Items enthält. Jetzt reinschauen!
Die GESIS Pretest-Datenbank stellt Ihnen Ergebnisse der kognitiven Pretests zur Verfügung, die bei GESIS durchgeführt wurden. Beispielsweise können Sie für eine Frage folgende Informationen finden: Wie verstehen Befragte die Frage oder bestimmte Begriffe? Wird die Frage im intendierten Sinne beantwortet? Ist die Frage einfach zu beantworten? Die Datenbank kann entweder anhand der Themenliste links oder mit Hilfe der Suchfunktion durchsucht werden.
In unserem GESIS-Pretest-Labor unterstützen wir Sie bei der Optimierung Ihrer Fragen und Erhebungsinstrumente. Finden Sie in unserer Pretest-Datenbank die Ergebnisse der kognitiven Pretests, die bei GESIS durchgeführt wurden.
🦓1 hour until TONIGHT'S #TumorBoardTuesday!!
🇧🇷@RachelRiechelm2 @jessrzanotti take us through treatment of hypermutation induced by alkylating agent in #PanCan
🦓Finish dinner, grab a drink, and prepare your 🧠 with these #CME
👇🏽See you soon!
---
RT @TumorBoardTues
#TumorBoardTuesday #PreTest Q1⃣
Free #CME🔗http://integrityce.com/TBT2023
📣B4 @RachelRiechelm2 @jessrzanotti teach us hypermutation #NETCancer test your🧠
🤔Which 2L fo…
https://twitter.com/TumorBoardTues/status/1653449001700556816
Tumor Board Tuesdays is a regularly scheduled, Twitter-based case discussion forum led by expert faculty exploring cases in various solid tumor malignancies. The series will focus on practice application in the clinic. Experts will present recent data and focus on realistic case examples. The advantage to this format is the ability to comment and receive feedback from the experts.
🫁under 1 hour until TONIGHT'S #TumorBoardTuesday!!
🫁 @LealTiciana @JennyCarlisleMD takes us through treating exon 20 insertion in #NSCLC
🫁 Grab a snack, get the last minute chair dances, and prepare your 🧠 with these #CME👇🏽
See you soon!
---
RT @TumorBoardTues
#TumorBoardTuesday
#PreTest Q1⃣
Free #CME 🔗 http://integrityce.com/TBT2023
@LealTiciana & @JennyCarlisleMD
🤔How would you Tx your 47yo♂️patient who developed multiple …
https://twitter.com/TumorBoardTues/status/1650901866161782784
Tumor Board Tuesdays is a regularly scheduled, Twitter-based case discussion forum led by expert faculty exploring cases in various solid tumor malignancies. The series will focus on practice application in the clinic. Experts will present recent data and focus on realistic case examples. The advantage to this format is the ability to comment and receive feedback from the experts.
#PreTest Q2️⃣ #TumorBoardTuesday @MPishvaian @JohnEbbenMDPhD @CCAlliance #ColonCancer #CRCAwarenessMonth
#CME 🔗 http://integrityce.com/tbt
🔬Path results for above 👨🏾🦳 who has undergone 1 cycle of FOLFOX
Disease KRAS wild type.
🤔What agent would you add to his treatment regimen?
#PreTest Q 1️⃣ #TumorBoardTuesday
Free #CME 🔗 http://integrityce.com/tbt
We’re back to GI oncology this week with @shafiarahman_ @RischZack to discuss EGFR!
Test your 🧠 with these❓
🤔What 1L tx would you pick for 62yo👨🏾🦳
ASx, L-side met #ColonCancer - unresectable liver mets?
⏳1 hour until TONIGHT'S #TumorBoardTuesday!!⏳
🫘@brian_rini @JVentoMD bring us the background of adjuvant therapy for #RenalCellCarcinoma
🥧This pie day, grab a piece, snuggle a baby, & prepare your 🧠 with these #CME
👇🏽👇🏽👇🏽
🫘See you soon!
---
RT @TumorBoardTues
#TumorBoardTuesday
👉B4 @BrianRini & @JVentoMD🗣️adjuvant Tx for #RenalCellCarcinoma test your🧠with these CME❓
Free #CME🔗http://integrityce.com/tbt
#PreTest Q1⃣
🧐Which IO…
https://twitter.com/TumorBoardTues/status/1635601446535155713
#TumorBoardTuesday #PreTest Q2️⃣
#CME eval🔗 http://integrityce.com/tbtEval
🤔Which of the following is a post-operative prediction model which provides a review of expected oncological outcomes in patients with RCC❓
#TumorBoardTuesday
👉B4 @BrianRini & @JVentoMD🗣️adjuvant Tx for #RenalCellCarcinoma test your🧠with these CME❓
Free #CME🔗http://integrityce.com/tbt
#PreTest Q1⃣
🧐Which IO agent is approved for adjuvant Tx after nephrectomy for patients with intermediate-high or high risk RCC❓